12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks saw significant movement. Bluejay Diagnostics, T2 Biosystems, Biomerica, Adamis Pharmaceuticals, Assure Hldgs, and TC BioPharm saw gains, while Aravive, Vicarious Surgical, Bio-Path Hldgs, Schrodinger, Outset Medical, and Staar Surgical experienced losses. The Q2 earnings reports for Schrodinger, Outset Medical, and Staar Surgical were released yesterday.
August 04, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aravive's stock decreased by 62.4% to $0.48 during Thursday's pre-market session.
The significant decrease in Aravive's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Schrodinger's stock declined by 19.79% to $40.3. The company's Q2 earnings report was released yesterday.
The decline in Schrodinger's stock price following the release of its Q2 earnings report suggests that the results did not meet investor expectations, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bluejay Diagnostics' shares moved upwards by 67.2% to $9.13 during Thursday's pre-market session.
The significant increase in Bluejay Diagnostics' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems' stock increased by 49.71% to $0.36. The company's market cap stands at $105.5 million.
The substantial increase in T2 Biosystems' stock price suggests positive investor sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100